ArticleCancers2022

Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer.

Yiting Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.